ID   TRBP2_HUMAN             Reviewed;         366 AA.
AC   Q15633; Q12878; Q8WY32; Q8WY33; Q9BRY2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 3.
DT   28-JUN-2023, entry version 205.
DE   RecName: Full=RISC-loading complex subunit TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034};
DE   AltName: Full=TAR RNA-binding protein 2;
DE   AltName: Full=Trans-activation-responsive RNA-binding protein;
GN   Name=TARBP2 {ECO:0000255|HAMAP-Rule:MF_03034}; Synonyms=TRBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION (MICROBIAL
RP   INFECTION), AND VARIANT PHE-251.
RX   PubMed=2011739; DOI=10.1126/science.2011739;
RA   Gatignol A., Buckler-White A.J., Berkhout B., Jeang K.T.;
RT   "Characterization of a human TAR RNA-binding protein that activates the
RT   HIV-1 LTR.";
RL   Science 251:1597-1600(1991).
RN   [2]
RP   SEQUENCE REVISION.
RA   Gatignol A., Duarte M.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PHE-251.
RX   PubMed=7774957; DOI=10.1016/0888-7543(95)80110-8;
RA   Kozak C.A., Gatignol A., Graham K., Jeang K.T., McBride O.W.;
RT   "Genetic mapping in human and mouse of the locus encoding TRBP, a protein
RT   that binds the TAR region of the human immunodeficiency virus (HIV-1).";
RL   Genomics 25:66-72(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-74, AND ALTERNATIVE PROMOTER USAGE.
RX   PubMed=11641396; DOI=10.1074/jbc.m104645200;
RA   Bannwarth S., Talakoub L., Letourneur F., Duarte M., Purcell D.F.,
RA   Hiscott J., Gatignol A.;
RT   "Organization of the human tarbp2 gene reveals two promoters that are
RT   repressed in an astrocytic cell line.";
RL   J. Biol. Chem. 276:48803-48813(2001).
RN   [8]
RP   CHARACTERIZATION OF RNA-BINDING.
RX   PubMed=8455607; DOI=10.1128/mcb.13.4.2193-2202.1993;
RA   Gatignol A., Buckler C., Jeang K.T.;
RT   "Relatedness of an RNA-binding motif in human immunodeficiency virus type 1
RT   TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila
RT   staufen.";
RL   Mol. Cell. Biol. 13:2193-2202(1993).
RN   [9]
RP   FUNCTION (MICROBIAL INFECTION), SELF-ASSOCIATION, AND INTERACTION WITH
RP   EIF2AK2.
RX   PubMed=11438532; DOI=10.1074/jbc.m103584200;
RA   Daher A., Longuet M., Dorin D., Bois F., Segeral E., Bannwarth S.,
RA   Battisti P.-L., Purcell D.F., Benarous R., Vaquero C., Meurs E.F.,
RA   Gatignol A.;
RT   "Two dimerization domains in the trans-activation response RNA-binding
RT   protein (TRBP) individually reverse the protein kinase R inhibition of HIV-
RT   1 long terminal repeat expression.";
RL   J. Biol. Chem. 276:33899-33905(2001).
RN   [10]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=12475984; DOI=10.1074/jbc.m208954200;
RA   Dorin D., Bonnet M.C., Bannwarth S., Gatignol A., Meurs E.F., Vaquero C.;
RT   "The TAR RNA-binding protein, TRBP, stimulates the expression of TAR-
RT   containing RNAs in vitro and in vivo independently of its ability to
RT   inhibit the dsRNA-dependent kinase PKR.";
RL   J. Biol. Chem. 278:4440-4448(2003).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH DICER1 AND AGO2.
RX   PubMed=16271387; DOI=10.1016/j.cell.2005.10.022;
RA   Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R.;
RT   "Human RISC couples microRNA biogenesis and posttranscriptional gene
RT   silencing.";
RL   Cell 123:631-640(2005).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SELF-ASSOCIATION, AND
RP   INTERACTION WITH DICER1.
RX   PubMed=16142218; DOI=10.1038/sj.embor.7400509;
RA   Haase A.D., Jaskiewicz L., Zhang H., Laine S., Sack R., Gatignol A.,
RA   Filipowicz W.;
RT   "TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts
RT   with Dicer and functions in RNA silencing.";
RL   EMBO Rep. 6:961-967(2005).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH DICER1 AND AGO2.
RX   PubMed=16357216; DOI=10.1101/gad.1384005;
RA   Maniataki E., Mourelatos Z.;
RT   "A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.";
RL   Genes Dev. 19:2979-2990(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH DICER1 AND
RP   AGO2, AND RNA-BINDING.
RX   PubMed=15973356; DOI=10.1038/nature03868;
RA   Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N.,
RA   Nishikura K., Shiekhattar R.;
RT   "TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene
RT   silencing.";
RL   Nature 436:740-744(2005).
RN   [15]
RP   FUNCTION, INTERACTION WITH DICER1; AGO2 AND PRKRA, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=16424907; DOI=10.1038/sj.emboj.7600942;
RA   Lee Y., Hur I., Park S.-Y., Kim Y.-K., Suh M.R., Kim V.N.;
RT   "The role of PACT in the RNA silencing pathway.";
RL   EMBO J. 25:522-532(2006).
RN   [16]
RP   FUNCTION, SELF-ASSOCIATION, INTERACTION WITH DICER1 AND PRKRA, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=17452327; DOI=10.1074/jbc.m611768200;
RA   Kok K.H., Ng M.-H., Ching Y.-P., Jin D.-Y.;
RT   "Human TRBP and PACT directly interact with each other and associate with
RT   dicer to facilitate the production of small interfering RNA.";
RL   J. Biol. Chem. 282:17649-17657(2007).
RN   [17]
RP   INTERACTION WITH DHX9.
RX   PubMed=17531811; DOI=10.1016/j.molcel.2007.04.016;
RA   Robb G.B., Rana T.M.;
RT   "RNA helicase A interacts with RISC in human cells and functions in RISC
RT   loading.";
RL   Mol. Cell 26:523-537(2007).
RN   [18]
RP   INTERACTION WITH DICER1; AGO2; EIF6; RPL7A AND MOV10, AND ASSOCIATION WITH
RP   THE 60S RIBOSOME.
RX   PubMed=17507929; DOI=10.1038/nature05841;
RA   Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I.,
RA   Liebhaber S.A., Pasquinelli A.E., Shiekhattar R.;
RT   "MicroRNA silencing through RISC recruitment of eIF6.";
RL   Nature 447:823-828(2007).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, AND INTERACTION WITH DICER1
RP   AND AGO2.
RX   PubMed=18178619; DOI=10.1073/pnas.0710869105;
RA   MacRae I.J., Ma E., Zhou M., Robinson C.V., Doudna J.A.;
RT   "In vitro reconstitution of the human RISC-loading complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:512-517(2008).
RN   [21]
RP   SELF-ASSOCIATION, INTERACTION WITH EIF2AK2 AND PRKRA, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18421256; DOI=10.4161/rna.5.2.6069;
RA   Laraki G., Clerzius G., Daher A., Melendez-Pena C., Daniels S.,
RA   Gatignol A.;
RT   "Interactions between the double-stranded RNA-binding proteins TRBP and
RT   PACT define the Medipal domain that mediates protein-protein
RT   interactions.";
RL   RNA Biol. 5:92-103(2008).
RN   [22]
RP   RETRACTED PAPER.
RX   PubMed=19219043; DOI=10.1038/ng.317;
RA   Melo S.A., Ropero S., Moutinho C., Aaltonen L.A., Yamamoto H., Calin G.A.,
RA   Rossi S., Fernandez A.F., Carneiro F., Oliveira C., Ferreira B., Liu C.-G.,
RA   Villanueva A., Capella G., Schwartz S. Jr., Shiekhattar R., Esteller M.;
RT   "A TARBP2 mutation in human cancer impairs microRNA processing and DICER1
RT   function.";
RL   Nat. Genet. 41:365-370(2009).
RN   [23]
RP   RETRACTION NOTICE OF PUBMED:19219043 NOTICE FOR PUBMED:19219043.
RX   PubMed=26813765; DOI=10.1038/ng0216-221;
RA   Melo S.A., Ropero S., Moutinho C., Aaltonen L.A., Yamamoto H., Calin G.A.,
RA   Rossi S., Fernandez A.F., Carneiro F., Oliveira C., Ferreira B., Liu C.-G.,
RA   Villanueva A., Capella G., Schwartz S. Jr., Shiekhattar R., Esteller M.;
RT   "Retraction: A TARBP2 mutation in human cancer impairs microRNA processing
RT   and DICER1 function.";
RL   Nat. Genet. 48:221-221(2016).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   INTERACTION WITH EBOLAVIRUS VP30 (MICROBIAL INFECTION), AND INTERACTION
RP   WITH EBOLAVIRUS VP35 (MICROBIAL INFECTION).
RX   PubMed=21228243; DOI=10.1128/jvi.01160-10;
RA   Fabozzi G., Nabel C.S., Dolan M.A., Sullivan N.J.;
RT   "Ebolavirus proteins suppress the effects of small interfering RNA by
RT   direct interaction with the mammalian RNA interference pathway.";
RL   J. Virol. 85:2512-2523(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   FUNCTION (MICROBIAL INFECTION).
RX   PubMed=30626973; DOI=10.1038/s41586-018-0841-4;
RA   Ringeard M., Marchand V., Decroly E., Motorin Y., Bennasser Y.;
RT   "FTSJ3 is an RNA 2'-O-methyltransferase recruited by HIV to avoid innate
RT   immune sensing.";
RL   Nature 565:500-504(2019).
RN   [28]
RP   STRUCTURE BY NMR OF 150-225.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second DSRBD of TAR RNA-binding protein 2.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Required for formation of the RNA induced silencing complex
CC       (RISC). Component of the RISC loading complex (RLC), also known as the
CC       micro-RNA (miRNA) loading complex (miRLC), which is composed of DICER1,
CC       AGO2 and TARBP2. Within the RLC/miRLC, DICER1 and TARBP2 are required
CC       to process precursor miRNAs (pre-miRNAs) to mature miRNAs and then load
CC       them onto AGO2. AGO2 bound to the mature miRNA constitutes the minimal
CC       RISC and may subsequently dissociate from DICER1 and TARBP2. May also
CC       play a role in the production of short interfering RNAs (siRNAs) from
CC       double-stranded RNA (dsRNA) by DICER1. {ECO:0000255|HAMAP-
CC       Rule:MF_03034, ECO:0000269|PubMed:15973356,
CC       ECO:0000269|PubMed:16142218, ECO:0000269|PubMed:16271387,
CC       ECO:0000269|PubMed:16357216, ECO:0000269|PubMed:16424907,
CC       ECO:0000269|PubMed:17452327, ECO:0000269|PubMed:18178619}.
CC   -!- FUNCTION: (Microbial infection) Binds to the HIV-1 TAR RNA which is
CC       located in the long terminal repeat (LTR) of HIV-1, and stimulates
CC       translation of TAR-containing RNAs (PubMed:2011739, PubMed:11438532,
CC       PubMed:12475984). This is achieved in part at least by binding to and
CC       inhibiting EIF2AK2/PKR, thereby reducing phosphorylation and inhibition
CC       of EIF2S1/eIF-2-alpha (PubMed:11438532). May also promote translation
CC       of TAR-containing RNAs independently of EIF2AK2/PKR (PubMed:12475984).
CC       Mediates recruitment of FTSJ3 methyltransferase to HIV-1 RNA, leading
CC       to 2'-O-methylation of the viral genome, allowing HIV-1 to escape the
CC       innate immune system (PubMed:30626973). {ECO:0000269|PubMed:11438532,
CC       ECO:0000269|PubMed:12475984, ECO:0000269|PubMed:2011739,
CC       ECO:0000269|PubMed:30626973}.
CC   -!- SUBUNIT: Self-associates. Component of the RISC loading complex (RLC),
CC       or micro-RNA (miRNA) loading complex (miRLC), which is composed of
CC       DICER1, AGO2 and TARBP2. Note that the trimeric RLC/miRLC is also
CC       referred to as RISC. Interacts with EIF2AK2/PKR and inhibits its
CC       protein kinase activity. Interacts with DHX9 and PRKRA. Interacts with
CC       DICER1, AGO2, MOV10, EIF6 and RPL7A (60S ribosome subunit); they form a
CC       large RNA-induced silencing complex (RISC) (PubMed:17507929).
CC       {ECO:0000255|HAMAP-Rule:MF_03034, ECO:0000269|PubMed:11438532,
CC       ECO:0000269|PubMed:15973356, ECO:0000269|PubMed:16142218,
CC       ECO:0000269|PubMed:16271387, ECO:0000269|PubMed:16357216,
CC       ECO:0000269|PubMed:16424907, ECO:0000269|PubMed:17452327,
CC       ECO:0000269|PubMed:17507929, ECO:0000269|PubMed:17531811,
CC       ECO:0000269|PubMed:18178619, ECO:0000269|PubMed:18421256}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with FTSJ3; forms a complex
CC       with FTSJ3 and HIV-1 TAR RNA. {ECO:0000269|PubMed:30626973}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with ebolavirus VP30; this
CC       interaction, which occurs only in the presence of siRNA, prevents
CC       TARBP2 binding to DICER1 and thus allows the virus to counteract host
CC       RNA silencing. {ECO:0000269|PubMed:21228243}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with ebolavirus VP35; this
CC       interaction prevents TARBP2 binding to DICER1 and thus allows the virus
CC       to counteract host RNA silencing. {ECO:0000269|PubMed:21228243}.
CC   -!- INTERACTION:
CC       Q15633; P55265-1: ADAR; NbExp=2; IntAct=EBI-978581, EBI-6913056;
CC       Q15633; P55265-5: ADAR; NbExp=3; IntAct=EBI-978581, EBI-6913210;
CC       Q15633; P78563-4: ADARB1; NbExp=3; IntAct=EBI-978581, EBI-12002366;
CC       Q15633; Q9UKV8: AGO2; NbExp=12; IntAct=EBI-978581, EBI-528269;
CC       Q15633; Q9UPY3: DICER1; NbExp=25; IntAct=EBI-978581, EBI-395506;
CC       Q15633; Q9UPY3-1: DICER1; NbExp=5; IntAct=EBI-978581, EBI-15569571;
CC       Q15633; P19525: EIF2AK2; NbExp=2; IntAct=EBI-978581, EBI-640775;
CC       Q15633; Q96T60: PNKP; NbExp=3; IntAct=EBI-978581, EBI-1045072;
CC       Q15633; O75569: PRKRA; NbExp=13; IntAct=EBI-978581, EBI-713955;
CC       Q15633; Q96SI9: STRBP; NbExp=3; IntAct=EBI-978581, EBI-740355;
CC       Q15633; Q15633: TARBP2; NbExp=5; IntAct=EBI-978581, EBI-978581;
CC       Q15633; Q15560: TCEA2; NbExp=3; IntAct=EBI-978581, EBI-710310;
CC       Q15633; Q8N8B7: TCEANC; NbExp=3; IntAct=EBI-978581, EBI-954696;
CC       Q15633; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-978581, EBI-11955057;
CC       Q15633; Q9HA38: ZMAT3; NbExp=3; IntAct=EBI-978581, EBI-2548480;
CC       Q15633; Q9H898-2: ZMAT4; NbExp=3; IntAct=EBI-978581, EBI-11529334;
CC       Q15633; Q9UL40: ZNF346; NbExp=6; IntAct=EBI-978581, EBI-2462313;
CC       Q15633; P0DTC9: N; Xeno; NbExp=5; IntAct=EBI-978581, EBI-25475856;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, perinuclear region.
CC       Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1; Synonyms=TRBP2;
CC         IsoId=Q15633-1; Sequence=Displayed;
CC       Name=2; Synonyms=TRBP1;
CC         IsoId=Q15633-2; Sequence=VSP_035584;
CC   -!- SIMILARITY: Belongs to the TARBP2 family. {ECO:0000255|HAMAP-
CC       Rule:MF_03034}.
CC   -!- CAUTION: A paper describing truncating mutations of TARBP2 in tumor
CC       cells and resultant effects on DICER1 stability and miRNA processing
CC       has been retracted, due to concerns of image duplication in some of the
CC       figures. {ECO:0000305|PubMed:19219043, ECO:0000305|PubMed:26813765}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M60801; AAA36765.1; -; mRNA.
DR   EMBL; U08998; AAB50581.2; -; mRNA.
DR   EMBL; BT007140; AAP35804.1; -; mRNA.
DR   EMBL; CH471054; EAW96720.1; -; Genomic_DNA.
DR   EMBL; BC005860; AAH05860.1; -; mRNA.
DR   EMBL; AF281068; AAL55730.1; -; Genomic_DNA.
DR   EMBL; AF281068; AAL55731.1; -; Genomic_DNA.
DR   CCDS; CCDS41791.1; -. [Q15633-2]
DR   CCDS; CCDS8861.1; -. [Q15633-1]
DR   PIR; G01420; G01420.
DR   RefSeq; NP_004169.3; NM_004178.4. [Q15633-2]
DR   RefSeq; NP_599150.1; NM_134323.1. [Q15633-1]
DR   RefSeq; NP_599151.2; NM_134324.2. [Q15633-2]
DR   RefSeq; XP_005269171.1; XM_005269114.1.
DR   RefSeq; XP_005269172.1; XM_005269115.2. [Q15633-2]
DR   PDB; 2CPN; NMR; -; A=150-225.
DR   PDB; 3ADL; X-ray; 2.20 A; A=161-231.
DR   PDB; 3LLH; X-ray; 2.14 A; A/B=22-105.
DR   PDB; 4WYQ; X-ray; 3.20 A; B/E=289-363.
DR   PDB; 5N8L; NMR; -; A=16-227.
DR   PDB; 5N8M; NMR; -; A=16-227.
DR   PDB; 5ZAK; EM; 4.40 A; B=1-366.
DR   PDB; 5ZAL; EM; 4.70 A; B=1-366.
DR   PDB; 5ZAM; EM; 5.70 A; B=1-366.
DR   PDB; 6ZBK; X-ray; 1.49 A; B=262-366.
DR   PDBsum; 2CPN; -.
DR   PDBsum; 3ADL; -.
DR   PDBsum; 3LLH; -.
DR   PDBsum; 4WYQ; -.
DR   PDBsum; 5N8L; -.
DR   PDBsum; 5N8M; -.
DR   PDBsum; 5ZAK; -.
DR   PDBsum; 5ZAL; -.
DR   PDBsum; 5ZAM; -.
DR   PDBsum; 6ZBK; -.
DR   AlphaFoldDB; Q15633; -.
DR   BMRB; Q15633; -.
DR   SMR; Q15633; -.
DR   BioGRID; 112758; 163.
DR   ComplexPortal; CPX-134; RISC-loading complex, TARBP2 variant.
DR   CORUM; Q15633; -.
DR   DIP; DIP-29665N; -.
DR   IntAct; Q15633; 60.
DR   MINT; Q15633; -.
DR   STRING; 9606.ENSP00000266987; -.
DR   BindingDB; Q15633; -.
DR   ChEMBL; CHEMBL2098; -.
DR   GlyGen; Q15633; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q15633; -.
DR   PhosphoSitePlus; Q15633; -.
DR   BioMuta; TARBP2; -.
DR   DMDM; 209572714; -.
DR   EPD; Q15633; -.
DR   jPOST; Q15633; -.
DR   MassIVE; Q15633; -.
DR   MaxQB; Q15633; -.
DR   PaxDb; Q15633; -.
DR   PeptideAtlas; Q15633; -.
DR   ProteomicsDB; 60666; -. [Q15633-1]
DR   ProteomicsDB; 60667; -. [Q15633-2]
DR   Antibodypedia; 15253; 453 antibodies from 35 providers.
DR   DNASU; 6895; -.
DR   Ensembl; ENST00000266987.7; ENSP00000266987.2; ENSG00000139546.11. [Q15633-1]
DR   Ensembl; ENST00000394357.6; ENSP00000377885.2; ENSG00000139546.11. [Q15633-2]
DR   Ensembl; ENST00000456234.6; ENSP00000416077.2; ENSG00000139546.11. [Q15633-2]
DR   GeneID; 6895; -.
DR   KEGG; hsa:6895; -.
DR   MANE-Select; ENST00000266987.7; ENSP00000266987.2; NM_134323.2; NP_599150.1.
DR   UCSC; uc001sdo.4; human. [Q15633-1]
DR   AGR; HGNC:11569; -.
DR   CTD; 6895; -.
DR   DisGeNET; 6895; -.
DR   GeneCards; TARBP2; -.
DR   HGNC; HGNC:11569; TARBP2.
DR   HPA; ENSG00000139546; Low tissue specificity.
DR   MIM; 605053; gene.
DR   neXtProt; NX_Q15633; -.
DR   OpenTargets; ENSG00000139546; -.
DR   PharmGKB; PA36334; -.
DR   VEuPathDB; HostDB:ENSG00000139546; -.
DR   eggNOG; KOG3732; Eukaryota.
DR   GeneTree; ENSGT00940000157748; -.
DR   HOGENOM; CLU_048292_2_0_1; -.
DR   InParanoid; Q15633; -.
DR   OMA; GYSCTWD; -.
DR   OrthoDB; 3130057at2759; -.
DR   PhylomeDB; Q15633; -.
DR   TreeFam; TF315953; -.
DR   PathwayCommons; Q15633; -.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-426486; Small interfering RNA (siRNA) biogenesis.
DR   SignaLink; Q15633; -.
DR   SIGNOR; Q15633; -.
DR   BioGRID-ORCS; 6895; 13 hits in 1158 CRISPR screens.
DR   EvolutionaryTrace; Q15633; -.
DR   GeneWiki; TARBP2; -.
DR   GenomeRNAi; 6895; -.
DR   Pharos; Q15633; Tchem.
DR   PRO; PR:Q15633; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q15633; protein.
DR   Bgee; ENSG00000139546; Expressed in right hemisphere of cerebellum and 132 other tissues.
DR   ExpressionAtlas; Q15633; baseline and differential.
DR   Genevisible; Q15633; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016442; C:RISC complex; IDA:UniProtKB.
DR   GO; GO:0070578; C:RISC-loading complex; IDA:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0035198; F:miRNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0070883; F:pre-miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0036002; F:pre-mRNA binding; TAS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0035197; F:siRNA binding; IDA:UniProtKB.
DR   GO; GO:0098795; P:global gene silencing by mRNA cleavage; IMP:UniProtKB.
DR   GO; GO:0035196; P:miRNA processing; IDA:UniProtKB.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0050689; P:negative regulation of defense response to virus by host; IDA:UniProtKB.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; TAS:UniProtKB.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IEA:Ensembl.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IDA:UniProtKB.
DR   GO; GO:0031054; P:pre-miRNA processing; IDA:UniProtKB.
DR   GO; GO:1903798; P:regulation of miRNA processing; IEA:Ensembl.
DR   GO; GO:0070920; P:regulation of regulatory ncRNA processing; IBA:GO_Central.
DR   GO; GO:0070921; P:regulation of siRNA processing; IEA:InterPro.
DR   GO; GO:0046782; P:regulation of viral transcription; IDA:UniProtKB.
DR   GO; GO:0070922; P:RISC complex assembly; IDA:UniProtKB.
DR   GO; GO:0007338; P:single fertilization; IEA:Ensembl.
DR   GO; GO:0030422; P:siRNA processing; IDA:UniProtKB.
DR   GO; GO:0043403; P:skeletal muscle tissue regeneration; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   CDD; cd19890; DSRM_TARBP2_rpt1; 1.
DR   CDD; cd10844; DSRM_TARBP2_rpt2; 1.
DR   CDD; cd19893; DSRM_TARBP2_rpt3; 1.
DR   Gene3D; 3.30.160.20; -; 3.
DR   HAMAP; MF_03034; TRBP2; 1.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR028605; TRBP2.
DR   InterPro; IPR044469; TRBP2_DSRM_1.
DR   InterPro; IPR044470; TRBP2_DSRM_2.
DR   InterPro; IPR044471; TRBP2_DSRM_3.
DR   PANTHER; PTHR46205; LOQUACIOUS, ISOFORM B; 1.
DR   PANTHER; PTHR46205:SF1; RISC-LOADING COMPLEX SUBUNIT TARBP2; 1.
DR   Pfam; PF00035; dsrm; 2.
DR   SMART; SM00358; DSRM; 3.
DR   SUPFAM; SSF54768; dsRNA-binding domain-like; 3.
DR   PROSITE; PS50137; DS_RBD; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Cytoplasm; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; RNA-binding;
KW   RNA-mediated gene silencing; Translation regulation.
FT   CHAIN           1..366
FT                   /note="RISC-loading complex subunit TARBP2"
FT                   /id="PRO_0000065622"
FT   DOMAIN          30..97
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03034"
FT   DOMAIN          159..227
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03034"
FT   DOMAIN          293..361
FT                   /note="DRBM 3"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03034"
FT   REGION          22..105
FT                   /note="Sufficient for interaction with PRKRA"
FT   REGION          152..234
FT                   /note="Sufficient for interaction with PRKRA"
FT   REGION          228..366
FT                   /note="Sufficient for interaction with DICER1"
FT   REGION          287..366
FT                   /note="Sufficient for interaction with PRKRA"
FT   MOD_RES         152
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..21
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2011739"
FT                   /id="VSP_035584"
FT   VARIANT         251
FT                   /note="S -> F (in dbSNP:rs1126500)"
FT                   /evidence="ECO:0000269|PubMed:2011739,
FT                   ECO:0000269|PubMed:7774957"
FT                   /id="VAR_046992"
FT   CONFLICT        144
FT                   /note="P -> A (in Ref. 1; AAA36765)"
FT                   /evidence="ECO:0000305"
FT   HELIX           21..25
FT                   /evidence="ECO:0007829|PDB:5N8L"
FT   HELIX           31..41
FT                   /evidence="ECO:0007829|PDB:3LLH"
FT   STRAND          47..53
FT                   /evidence="ECO:0007829|PDB:3LLH"
FT   STRAND          57..59
FT                   /evidence="ECO:0007829|PDB:5N8L"
FT   STRAND          62..68
FT                   /evidence="ECO:0007829|PDB:3LLH"
FT   STRAND          71..79
FT                   /evidence="ECO:0007829|PDB:3LLH"
FT   HELIX           80..95
FT                   /evidence="ECO:0007829|PDB:3LLH"
FT   HELIX           161..170
FT                   /evidence="ECO:0007829|PDB:3ADL"
FT   STRAND          177..185
FT                   /evidence="ECO:0007829|PDB:3ADL"
FT   STRAND          187..189
FT                   /evidence="ECO:0007829|PDB:2CPN"
FT   STRAND          191..198
FT                   /evidence="ECO:0007829|PDB:3ADL"
FT   STRAND          201..209
FT                   /evidence="ECO:0007829|PDB:3ADL"
FT   HELIX           210..226
FT                   /evidence="ECO:0007829|PDB:3ADL"
FT   HELIX           265..270
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   HELIX           274..281
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   HELIX           285..289
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   HELIX           291..293
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   HELIX           294..305
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   STRAND          309..316
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   STRAND          323..329
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   STRAND          331..333
FT                   /evidence="ECO:0007829|PDB:4WYQ"
FT   STRAND          335..343
FT                   /evidence="ECO:0007829|PDB:6ZBK"
FT   HELIX           344..364
FT                   /evidence="ECO:0007829|PDB:6ZBK"
SQ   SEQUENCE   366 AA;  39039 MW;  768BA11751DA4912 CRC64;
     MSEEEQGSGT TTGCGLPSIE QMLAANPGKT PISLLQEYGT RIGKTPVYDL LKAEGQAHQP
     NFTFRVTVGD TSCTGQGPSK KAAKHKAAEV ALKHLKGGSM LEPALEDSSS FSPLDSSLPE
     DIPVFTAAAA ATPVPSVVLT RSPPMELQPP VSPQQSECNP VGALQELVVQ KGWRLPEYTV
     TQESGPAHRK EFTMTCRVER FIEIGSGTSK KLAKRNAAAK MLLRVHTVPL DARDGNEVEP
     DDDHFSIGVG SRLDGLRNRG PGCTWDSLRN SVGEKILSLR SCSLGSLGAL GPACCRVLSE
     LSEEQAFHVS YLDIEELSLS GLCQCLVELS TQPATVCHGS ATTREAARGE AARRALQYLK
     IMAGSK
//
